Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation

Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics

(2014) Kelly A Newell et al.   BMC Psychiatry

Existence of monomer and dimer forms of mGluR5, under reducing conditions in studies of postmortem brain in various psychiatric disorders

(2014) S. Hossein Fatemi et al.   SCHIZOPHRENIA RESEARCH

Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness

(2013) Robert E McCullumsmith et al.   NEUROPSYCHOPHARMACOLOGY

Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment

(2013) Natalie Matosin et al.   SCHIZOPHRENIA RESEARCH

Rethinking schizophrenia in the context of normal neurodevelopment

(2013) Vibeke S. Catts et al.   Frontiers in Cellular Neuroscience

Support for the N -Methyl-D-Aspartate Receptor Hypofunction Hypothesis of Schizophrenia From Exome Sequencing in Multiplex Families

(2013) Andrew E. Timms et al.   JAMA Psychiatry

mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway

(2013) S H Fatemi et al.   Translational Psychiatry

Functional Consequences of Mutations in Postsynaptic Scaffolding Proteins and Relevance to Psychiatric Disorders

(2012) Jonathan T. Ting et al.   Annual Review of Neuroscience

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

(2012) S Miyamoto et al.   MOLECULAR PSYCHIATRY

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia

(2012) C S Weickert et al.   MOLECULAR PSYCHIATRY

Preso1, mGluR5 and the machinery of pain

(2012) Jelena Radulovic et al.   NATURE NEUROSCIENCE

Preso1 dynamically regulates group I metabotropic glutamate receptors

(2012) Jia-Hua Hu et al.   NATURE NEUROSCIENCE

Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia

(2012) Natalie Matosin et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling

(2012) D. El Moustaine et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet?

(2012) D. C. Javitt   SCHIZOPHRENIA BULLETIN

Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition

(2011) Olivia Engmann et al.   BRAIN

Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels

(2011) Katrina Weston-Green et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Altered levels of glutamatergic receptors and Na+/K+ ATPase-α1 in the prefrontal cortex of subjects with schizophrenia

(2011) Corrado Corti et al.   SCHIZOPHRENIA RESEARCH

Alterations in Metabotropic Glutamate Receptor 1α and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia

(2010) David W. Volk et al.   AMERICAN JOURNAL OF PSYCHIATRY

Selection of Reference Gene Expression in a Schizophrenia Brain Cohort

(2010) Cynthia Shannon Weickert et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

(2010) Ilja Spellmann et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia

(2010) A Piton et al.   MOLECULAR PSYCHIATRY

Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future

(2010) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Preso, A Novel PSD-95-Interacting FERM and PDZ Domain Protein That Regulates Dendritic Spine Morphogenesis

(2009) H. W. Lee et al.   JOURNAL OF NEUROSCIENCE

Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling

(2009) H. Wang et al.   SCIENCE

Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology

(2008) K. Fuxe et al.   BRAIN RESEARCH REVIEWS

Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain

(2007) Mei Han et al.   JOURNAL OF NEUROSCIENCE RESEARCH